Article

Distinct Gastrointestinal Symptom Phenotypes in Adults with Cystic Fibrosis are linked to complications and medication use

2026-01-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background and aims</h4> Gastrointestinal symptoms remain common in adults with cystic fibrosis (CF) despite cystic fibrosis transmembrane conductance regulator modulator use, suggesting persistent and heterogeneous gut dysfunction. This prospective observational study tests the hypothesis that distinct gut symptom phenotypes in CF can be observed and linked to underlying mechanisms. <h4>Me...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 77ca2739-9134-5623-ad18-a2bf2609d4c1
DOI: 10.64898/2026.01.16.26344251

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Distinct Gastrointestinal Symptom Phenotypes in Adults with Cystic Fibrosis are linked to complications and medication useDOI 10.64898/2026.01.16.26344251Read

Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings.Semantic proximity Read

The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis.Semantic proximity Read

Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.Semantic proximity Read

Patient-reported Symptoms Are Independent of Extent of Disease in Longstanding Ulcerative Colitis: Magic in Imagine.Semantic proximity Read

Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS.Semantic proximity Read

Distal intestinal obstruction syndrome in adults with cystic fibrosis.Semantic proximity Read

Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged ≥12 years – The RECOVER studySemantic proximity Read

Interpreting ME/CFS Patient Clusters Through a Regional Gut-Barrier ModelSemantic proximity Read

Factors Affecting Symptom Severity And Quality Of Life In Patients With Outlet Obstructive Constipation: A Cross-Sectional StudySemantic proximity Read

Subgrouping patients with comorbidity between functional dyspepsia and irritable bowel syndrome: application of multidimensional item response theory and latent profile analysisSemantic proximity Read

Background Factors Involved in the Epidemiology of Functional Constipation in the Japanese PopulationSemantic proximity Read

Cystic fibrosis-associated inflammatory bowel disease: a case series and literature review.Semantic proximity Read